CAPN3 mutations in patients with idiopathic eosinophilic myositis

Annals of Neurology

Volumn 59, Issue 6, 2006, Pages 905-911

  Krahn, Martin ^a   Lopez De Munain, Adolfo ^b   Streichenberger, Nathalie ^c   Bernard, Rafaëlle ^a   Pécheux, Christophe ^a   Testard, Hervé ^d   Pena Segura, José L ^e   Yoldi, Eugenia ^f   Cabello, Ana ^g   Romero, Norma B ^h   Poza, Juan J ^b   Bouillot Eimer, Sandrine ⁱ   Ferrer, Xavier ^j   Goicoechea, Maria ^b   Garcia Bragado, Federico ^f   Leturcq, France ^k   Urtizberea, J Andoni ^l   Lévy, Nicolas ^a,m  

^a TIMONE HOSPITAL   (France)

^b HOSPITAL DONOSTIA   (Spain)

^c HÔPITAL NEUROLOGIQUE   (France)

^d CHI   (France)

^e HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^f Universidad Pública de Navarra   (Spain)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ HÔPITAL PELLEGRIN   (France)

^j HAUT LÉVÊQUE HOSPITAL   (France)

^k Hôpital Cochin ^*  (France)

^l ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^m INSERM   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 3; CREATINE KINASE; TRYPTOPHAN;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CAPN3 GENE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIA; IDIOPATHIC DISEASE; IDIOPATHIC EOSINOPHILIC MYOSITIS; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; PARASITOSIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; RARE DISEASE; SCHOOL CHILD; SKELETAL MUSCLE; SYSTEMIC DISEASE;

BLOTTING, WESTERN; CALPAIN; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; EOSINOPHILIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE PROTEINS; MUTATION; MYOSITIS; POLYMERASE CHAIN REACTION;

EID: 33744792021     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20833     Document Type: Article

References (20)

1. Pickering MC, Walport MJ. Eosinophilic myopathic syndromes. Curr Opin Rheumatol 1998;10:504-510.
2. Richard I, Broux O, Allamand V, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995;81:27-40.
3. Saenz A, Leturcq F, Cobo AM, et al. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain 2005;128:732-742.
4. Baghdiguian S, Martin M, Richard I, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 1999;5:503-511.
5. Baghdiguian S, Richard I, Martin M, et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med 2001;79:254-261.
6. Haravuori H, Vihola A, Straub V, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: titin is the candidate gene. Neurology 2001;56:869-877.
7. Kramerova I, Kudryashova E, Tidball JG, Spencer MJ. Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum Mol Genet 2004;13: 1373-1388.
8. Romero NB, Marsac C, Paturneau-Jouas M, et al. Infantile familial cardiomyopathy due to mitochondrial complex I and IV associated deficiency. Neuromuscul Disord 1993;3:31-42.
9. Urtasun M, Saenz A, Roudaut C, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998;121(pt 9):1735-1747.
10. Anderson LV, Davison K, Moss JA, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998;153:1169-1179.
11. Pena Segura JL, Adrados I, Jimenez Bustos JM, et al. [Eosinophilic myositis in a 9 year old boy]. Rev Neurol 2001;33:960-963.
12. Arahata K, Ishihara T, Fukunaga H, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 1995;2:S56-S66.
13. Gallardo E, Rojas-Garcia R, de Luna N, et al. Inflammation in dysferlin myopathy: immunohistochemical characterization of 13 patients. Neurology 2001;57:2136-2138.
14. Fanin M, Fulizio L, Nascimbeni AC, et al. Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat 2004;24:52-62.
15. Schaub FJ, Liles WC, Ferri N, et al. Fas and Fas-associated death domain protein regulate monocyte chemoattractant protein-1 expression by human smooth muscle cells through caspase- and calpain-dependent release of interleukin-1alpha. Circ Res 2003;93:515-522.
16. Murata K, Sugie K, Takamure M, et al. Eosinophilic major basic protein and interleukin-5 in eosinophilic myositis. Eur J Neurol 2003;10:35-38.
17. Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ. Calpain 3 participates in sarcomere remodeling by acting up-stream of the ubiquitin-proteasome pathway. Hum Mol Genet 2005;14:2125-2134.
18. Piluso G, Politano L, Aurino S, et al. The extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes. J Med Genet 2005;42:686-693.
19. Richard I, Brenguier L, Dincer P, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet 1997;60:1128-1138.
20. Richard I, Roudaut C, Saenz A, et al. Calpainopathy: a survey of mutations and polymorphisms. Am J Hum Genet 1999;64: 1524-1540.